Fidelity Investments
ELDN icon

Fidelity Investments’s Eledon Pharmaceuticals ELDN Stock Holding History

Fidelity Investments’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.6K Buy
6,235
+615
+11% +$2.24K ﹤0.01% 4588
2026
Q1 		$17.3K Buy
5,620
+934
+20% +$2.2K ﹤0.01% 4574
2025
Q4 		$7.08K Buy
4,686
+4,441
+1,813% +$10.6K ﹤0.01% 4816
2025
Q3 		$635 Buy
245
+177
+260% +$517 ﹤0.01% 5070
2025
Q2 		$184 Buy
68
+51
+300% +$153 ﹤0.01% 5104
2025
Q1 		$58 Hold
17
– – ﹤0.01% 5145
2024
Q4 		$70 Hold
17
– – ﹤0.01% 5148
2024
Q3 		$42 Hold
17
– – ﹤0.01% 5224
2024
Q2 		$45 Hold
17
– – ﹤0.01% 5072
2024
Q1 		$35 Buy
+17
New +$30 ﹤0.01% 5083
2022
Q1 		– Sell
-504,371
Closed -$2.22M – 5084
2021
Q4 		$2.22M Sell
504,371
-499,740
-50% -$2.53M ﹤0.01% 2542
2021
Q3 		$6.21M Sell
1,004,111
-345,100
-26% -$2.41M ﹤0.01% 2298
2021
Q2 		$10.7M Hold
1,349,211
– – ﹤0.01% 2084
2021
Q1 		$14.4M Buy
1,349,211
+345,100
+34% +$5.21M ﹤0.01% 1911
2020
Q4 		$15.5M Buy
+1,004,111
New +$19.2M ﹤0.01% 1815
2016
Q3 		– Sell
-3,288
Closed -$2.94M – 2663
2016
Q2 		$2.94M Sell
3,288
-86
-3% -$94.9K ﹤0.01% 2290
2016
Q1 		$3.07M Sell
3,374
-175
-5% -$172K ﹤0.01% 2277
2015
Q4 		$5.01M Hold
3,549
– – ﹤0.01% 2195
2015
Q3 		$5.95M Hold
3,549
– – ﹤0.01% 2123
2015
Q2 		$7.65M Hold
3,549
– – ﹤0.01% 2116
2015
Q1 		$6.5M Hold
3,549
– – ﹤0.01% 2148
2014
Q4 		$8.48M Hold
3,549
– – ﹤0.01% 2060
2014
Q3 		$8.71M Buy
+3,549
New +$10.1M ﹤0.01% 2064

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Fidelity Investments's ELDN Position: Q2 2026 in Review

Fidelity Investments increased its Eledon Pharmaceuticals (ELDN) stake by 11% in Q2 2026, buying an estimated $2.24K and bringing the position to 6,235 shares worth $24.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4588.

Fidelity Investments first reported a position in ELDN in Q3 2014 and has held it in 23 quarters since. The position peaked at $15.5M in Q4 2020. 161 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • Fidelity Investments held 6,235 shares of Eledon Pharmaceuticals worth $24.6K as of Q2 2026.
  • Fidelity Investments bought 615 Eledon Pharmaceuticals shares in Q2 2026, an estimated $2.24K.
  • Eledon Pharmaceuticals made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4588 holding.
  • Fidelity Investments first reported a position in Eledon Pharmaceuticals in Q3 2014 and has held it in 23 quarters since.
  • Fidelity Investments's Eledon Pharmaceuticals position peaked at $15.5M in Q4 2020.
  • 161 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.